Zydus Lifesciences Share Price

1,045.55-7.41 (-0.71%)
Volume: 9,48,334

Live
Last Updated On: 29 May, 2024, 03:00 PM IST

STOCK SCORE

ETPrime Only

TECHNICALS
COMPARE

Overview
News
Analysis
Recos
Financials
Forecast
Technicals
Peers
Shareholdings
MF
F&O
Corp Actions
About
More
- MF
- F&O
- Corp Actions
- About
EnglishEnglishहिन्दी ગુજરાતી मराठी বাংলা ಕನ್ನಡ தமிழ்తెలుగు
Rank 127 - ET 5002023 ranking

Cadila Healthcare share price insights

View All

Intraday fact check
In the last 19 years, only 1.18 % trading sessions saw intraday declines higher than 5 % .
Quarterly Topline Performance
Company witnessed QoQ revenue growth of 25.25%, which is highest in the last 3 years. (Source: Consolidated Financials)
Sell Signal: Bear gaining steam
10 day moving crossover appeared yesterday. Average price decline of -2.31% within 7 days of this signal in last 5 years.
Stock Returns vs Nifty 100
Stock gave a 3 year return of 69.48% as compared to Nifty 100 which gave a return of 52.55%. (as of last trading session)
Cadila Healthcare Share Price Update
Zydus Lifesciences Ltd. share price moved down by -0.86% from its previous close of Rs 1,052.95. Zydus Lifesciences Ltd. stock last traded price is 1,043.90
Share Price Value
Today/Current/Last 1,043.901,044.20
Previous Day 1,052.951,050.35

Share Price	Value
Today/Current/Last	1,043.901,044.20
Previous Day	1,052.951,050.35

InsightsCadila Healthcare

Do you find these insights useful?

hate it
meh
love it

Key Metrics

PE Ratio

(x)

27.01

EPS - TTM

(₹)

38.99

MCap

(₹ Cr.)

1,05,951

Sectoral MCap Rank

PB Ratio

(x)

4.79

Div Yield

(%)

0.28

Face Value

(₹)

1.00

Beta

1.50

VWAP

(₹)

1,042.30

52W H/L

(₹)

1,172.50 / 498.85

Cadila Healthcare Share Price Returns

1 Day	-0.71%
1 Week	-3.25%
1 Month	8.56%
3 Months	11.0%
1 Year	104.19%
3 Years	68.28%
5 Years	296.42%

ET Stock ScreenersTop Score Companies

Check whether Cadila Healthcare belongs to analysts' top-rated companies list?

View Stock Screeners

Cadila Healthcare News & Analysis

View all Cadila Healthcare Share News & Announcements

Cadila Healthcare Share Analysis

Unlock Stock Score, Analyst' Ratings & Recommendations

View Stock Score on a 10-point scale
See ratings on Earning, Fundamentals, Valuation, Risk & Price
Check stock performance

JOIN ET PRIME

Cadila Healthcare Share Recommendations

Recent Recos

HOLD

Current

Mean Recos by 26 Analysts

Strong
SellSellHoldBuyStrong
Buy

That's all for Cadila Healthcare recommendations. Check out other stock recos.

Analyst Trends

Ratings	Current	1 Week Ago	1 Month Ago	3 Months Ago
Strong Buy	3	3	7	6
Buy	6	6	6	7
Hold	10	10	9	10
Sell	4	4	3	3
Strong Sell	3	3	2	2
# Analysts	26	26	27	28

View all Stock Recommendations

Cadila Healthcare Financials

Income (P&L)
Balance Sheet
Cash Flow
Ratios

Insights

Quarterly Topline Performance
Company witnessed QoQ revenue growth of 25.25%, which is highest in the last 3 years. (Source: Consolidated Financials)
Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 13.82% outperformed its 3 year CAGR of 11.01%. (Source: Consolidated Financials)

Quarterly \| Annual	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023
Total Income	5,690.20	4,542.90	4,422.80	5,175.60	5,048.40
Total Income Growth (%)	25.25	2.72	-14.55	2.52	14.72
Total Expenses	4,108.60	3,597.60	3,406.90	3,828.30	4,534.90
Total Expenses Growth (%)	14.20	5.60	-11.01	-15.58	26.39
EBIT	1,581.60	945.30	1,015.90	1,347.30	513.50
EBIT Growth (%)	67.31	-6.95	-24.60	162.38	-36.83
Profit after Tax (PAT)	1,246.10	789.60	800.70	1,086.90	296.60
PAT Growth (%)	57.81	-1.39	-26.33	266.45	-52.38
EBIT Margin (%)	27.80	20.81	22.97	26.03	10.17
Net Profit Margin (%)	21.90	17.38	18.10	21.00	5.88
Basic EPS (₹)	11.69	7.80	7.91	10.74	2.93

Quarterly \| Annual	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023
Total Income	3,693.50	2,478.10	2,693.80	3,038.10	2,830.50
Total Income Growth (%)	49.05	-8.01	-11.33	7.33	27.32
Total Expenses	1,902.40	1,799.90	1,634.80	1,935.90	2,130.50
Total Expenses Growth (%)	5.69	10.10	-15.55	-9.13	21.75
EBIT	1,791.10	678.20	1,059.00	1,102.20	700.00
EBIT Growth (%)	164.10	-35.96	-3.92	57.46	47.90
Profit after Tax (PAT)	1,405.20	450.40	805.00	780.90	490.70
PAT Growth (%)	211.99	-44.05	3.09	59.14	91.75
EBIT Margin (%)	48.49	27.37	39.31	36.28	24.73
Net Profit Margin (%)	38.05	18.18	29.88	25.70	17.34
Basic EPS (₹)	13.89	4.45	7.96	7.71	4.85

Quarterly \| Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	19,831.50	17,424.00	15,489.90	14,449.10	14,367.00
Total Revenue Growth (%)	13.82	12.49	7.20	0.57	7.48
Total Expenses	15,008.40	14,230.10	12,764.50	11,844.80	12,508.00
Total Expenses Growth (%)	5.47	11.48	7.76	-5.30	13.98
Profit after Tax (PAT)	3,972.80	1,960.30	4,487.30	2,133.60	1,176.60
PAT Growth (%)	102.66	-56.31	110.32	81.34	-36.36
Operating Profit Margin (%)	25.08	19.28	18.68	19.18	15.44
Net Profit Margin (%)	20.32	11.37	29.39	14.81	8.25
Basic EPS (₹)	38.14	19.30	43.83	20.84	11.49

Quarterly \| Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	11,903.50	9,280.00	8,160.60	7,869.30	7,196.80
Total Revenue Growth (%)	28.27	13.72	3.70	9.34	9.10
Total Expenses	7,655.10	7,044.00	6,677.40	5,993.30	5,587.10
Total Expenses Growth (%)	8.68	5.49	11.41	7.27	15.07
Profit after Tax (PAT)	3,441.50	1,529.20	857.90	1,476.20	1,412.90
PAT Growth (%)	125.05	78.25	-41.88	4.48	-4.90
Operating Profit Margin (%)	42.88	28.79	20.27	25.02	29.04
Net Profit Margin (%)	31.81	17.51	10.74	18.97	22.25
Basic EPS (₹)	34.01	15.06	8.38	14.42	13.80

All figures in Rs Cr, unless mentioned otherwise

View Details

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Assets	29,280.80	25,756.40	27,795.40	23,884.70	23,686.60
Total Assets Growth (%)	13.68	-7.34	16.37	0.84	0.87
Total Liabilities	7,179.20	6,068.10	8,741.60	8,955.10	11,976.20
Total Liabilities Growth (%)	18.31	-30.58	-2.38	-25.23	1.46
Total Equity	22,101.60	19,688.30	19,053.80	14,929.60	11,710.40
Total Equity Growth (%)	12.26	3.33	27.62	27.49	0.27
Current Ratio (x)	2.15	1.81	1.56	1.11	1.05
Total Debt to Equity (x)	0.04	0.07	0.25	0.35	0.68
Contingent Liabilities	0.00	1,274.90	1,210.70	1,295.50	1,053.70

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Assets	24,084.80	20,563.60	17,740.00	18,463.60	16,551.50
Total Assets Growth (%)	17.12	15.92	-3.92	11.55	21.07
Total Liabilities	8,368.30	6,924.20	4,499.50	5,719.10	5,291.30
Total Liabilities Growth (%)	20.86	53.89	-21.33	8.08	3.71
Total Equity	15,716.50	13,639.40	13,240.50	12,744.50	11,260.20
Total Equity Growth (%)	15.23	3.01	3.89	13.18	31.40
Current Ratio (x)	3.12	2.57	1.70	1.25	1.39
Total Debt to Equity (x)	0.39	0.35	0.20	0.31	0.26
Contingent Liabilities	0.00	752.40	2,233.10	2,009.30	4,090.90

All figures in Rs Cr, unless mentioned otherwise

View Details

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash flow from Operating Activities	3,227.90	2,688.80	2,104.10	3,293.90	2,931.50
Net Cash used in Investing Activities	-1,475.20	1,171.20	1,154.40	-724.60	-1,012.30
Net Cash flow from Financing Activities	-1,804.40	-4,400.40	-868.30	-2,547.70	-1,528.20
Net Cash Flow	-74.80	-533.80	2,372.90	-90.50	398.90
Closing Cash & Cash Equivalent	413.00	573.10	3,460.10	1,087.20	1,177.70
Closing Cash & Cash Equivalent Growth (%)	-27.94	-83.44	218.26	-7.68	51.22
Total Debt/ CFO (x)	0.24	0.43	1.99	1.39	2.40

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash flow from Operating Activities	1,999.10	1,078.20	1,310.70	2,225.30	1,180.60
Net Cash used in Investing Activities	-1,830.60	-1,959.70	768.20	-2,713.80	55.00
Net Cash flow from Financing Activities	-300.80	827.00	-1,709.80	257.20	-966.70
Net Cash Flow	-132.30	-54.50	369.10	-231.30	268.50
Closing Cash & Cash Equivalent	108.10	248.10	523.10	154.00	385.30
Closing Cash & Cash Equivalent Growth (%)	-56.43	-52.57	239.68	-60.03	229.88
Total Debt/ CFO (x)	3.09	4.47	2.03	1.76	2.50

All figures in Rs Cr, unless mentioned otherwise

View Details

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Return on Equity (%)	20.03	11.19	26.39	16.42	11.33
Return on Capital Employed (%)	20.48	16.43	14.29	17.24	14.27
Return on Assets (%)	13.56	7.61	16.14	8.93	4.96
Interest Coverage Ratio (x)	69.81	31.15	28.07	21.62	6.44
Asset Turnover Ratio (x)	0.71	0.36	0.38	0.37	60.17
Price to Earnings (x)	25.51	25.38	7.96	21.19	23.26
Price to Book (x)	5.10	2.84	2.10	3.47	2.64
EV/EBITDA (x)	18.18	12.97	11.46	14.79	12.00
EBITDA Margin (%)	28.99	23.47	23.35	23.83	20.32

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Return on Equity (%)	21.89	11.21	6.47	11.58	12.54
Return on Capital Employed (%)	21.53	14.14	11.80	14.27	14.07
Return on Assets (%)	14.28	7.43	4.83	7.99	8.53
Interest Coverage Ratio (x)	13.16	10.79	15.54	33.82	7.88
Asset Turnover Ratio (x)	0.48	0.46	0.44	0.44	38.34
Price to Earnings (x)	29.41	32.57	41.67	30.58	19.38
Price to Book (x)	6.43	3.65	2.70	3.54	2.43
EV/EBITDA (x)	20.78	18.09	18.15	20.39	13.17
EBITDA Margin (%)	47.54	34.39	26.26	30.82	35.80

Financial InsightsCadila Healthcare

Income (P&L)

- Quarterly Topline Performance
  Company witnessed QoQ revenue growth of 25.25%, which is highest in the last 3 years. (Source: Consolidated Financials)
- Beating 3 Yr Revenue CAGR
  Company's annual revenue growth of 13.82% outperformed its 3 year CAGR of 11.01%. (Source: Consolidated Financials)

Do you find these insights useful?

hate it
meh
love it

Cadila Healthcare Share Price Forecast

PRICE
REVENUE
EARNINGS

Get multiple analysts’ prediction on Cadila Healthcare
High, low, medium predictions for Price
Upcoming predictions for Revenue
Details about company earnings
START FREE TRIAL
Get multiple analysts’ prediction on Cadila Healthcare
High, low, medium predictions for Price
Upcoming predictions for Revenue
Details about company earnings
START FREE TRIAL
Get multiple analysts’ prediction on Cadila Healthcare
High, low, medium predictions for Price
Upcoming predictions for Revenue
Details about company earnings
START FREE TRIAL

Peer Comparison

Cadila Healthcare Stock Performance
Ratio Performance

CHART
TABLE

Insights

Stock Returns vs Nifty 100
Stock gave a 3 year return of 69.48% as compared to Nifty 100 which gave a return of 52.55%. (as of last trading session)
Stock Returns vs Nifty Pharma
Stock generated 69.48% return as compared to Nifty Pharma which gave investors 37.9% return over 3 year time period. (as of last trading session)

Choose from Peers
Choose from Stocks

NAME	1D	1W	1M	3M	1Y	3Y	5Y
Cadila Healthcare Stock Performance	-0.74	-3.28	8.52	10.97	104.12	68.23	296.28
Cipla Stock Performance	0.88	0.68	5.99	0.81	56.07	59.73	164.45
Divis Labs Stock Performance	1.09	9.39	11.30	27.26	27.66	7.76	179.39
Dr. Reddys Stock Performance	0.59	2.17	-4.72	-6.60	31.69	15.51	129.82
Torrent Pharma Stock Performance	1.90	2.01	1.11	1.92	59.28	100.23	259.67
Add More

Insights

Stock Returns vs Nifty 100
Stock gave a 3 year return of 69.48% as compared to Nifty 100 which gave a return of 52.55%. (as of last trading session)
Stock Returns vs Nifty Pharma
Stock generated 69.48% return as compared to Nifty Pharma which gave investors 37.9% return over 3 year time period. (as of last trading session)

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Cadila Healthcare	27.01	4.79	20.03	20.48	13.56	11.01	25.08	19.71	38.14	2.15	0.04	0.24
Cipla	28.98	4.46	15.43	21.79	12.59	10.82	23.22	16.12	51.05	3.71	0.01	0.06
Divis Labs	72.87	8.59	11.78	15.26	10.34	5.13	27.60	20.39	60.27	7.57	0.00	0.00
Dr. Reddys	17.84	3.52	19.74	25.13	14.35	14.18	26.26	19.86	335.22	2.59	0.06	0.36
Torrent Pharma	54.50	13.16	24.15	27.17	10.99	10.08	24.40	15.43	48.94	1.03	0.57	1.21
Add More

Annual Ratios (%)

Choose from Peers

Mankind Pharma
Lupin
Aurobindo Pharma
Alkem Labs
Biocon

Choose from Stocks

See All Parameters

Peers InsightsCadila Healthcare

Stock Returns vs Nifty 100
Stock gave a 3 year return of 69.48% as compared to Nifty 100 which gave a return of 52.55%. (as of last trading session)
Stock Returns vs Nifty Pharma
Stock generated 69.48% return as compared to Nifty Pharma which gave investors 37.9% return over 3 year time period. (as of last trading session)

Do you find these insights useful?

hate it
meh
love it

Cadila Healthcare Shareholding Pattern

QOQ Change
Total Shareholdings

Loading...
Showing Cadila Healthcare Shareholding as on 31 Mar 2024
Category 31 Mar 2024 31 Dec 2023 30 Sep 2023 30 Jun 2023
Promoters 74.98 74.98 74.98 74.98
Pledge 0.00 0.00 0.00 0.00
FII 5.72 4.99 4.85 4.04
DII 12.55 12.94 13.01 13.44
Mutual Funds 6.71 6.99 5.94 5.80
Others 6.75 7.09 7.15 7.53
Showing Shareholding as on 31 Mar 2024
Category No. of Shares Percentage % Change QoQ
Promoters 75,45,04,049 74.98 % 0.00
Pledge 0 0.00 % 0.00
FII 5,75,70,263 5.72 % 0.72
DII 12,63,34,616 12.55 % -0.38
MF 6,75,54,708 6.71 % -0.28
Others 6,78,25,062 6.75 % -0.34

Category	31 Mar 2024	31 Dec 2023	30 Sep 2023	30 Jun 2023
Promoters	74.98	74.98	74.98	74.98
Pledge	0.00	0.00	0.00	0.00
FII	5.72	4.99	4.85	4.04
DII	12.55	12.94	13.01	13.44
Mutual Funds	6.71	6.99	5.94	5.80
Others	6.75	7.09	7.15	7.53

Category	No. of Shares	Percentage	% Change QoQ
Promoters	75,45,04,049	74.98 %	0.00
Pledge	0	0.00 %	0.00
FII	5,75,70,263	5.72 %	0.72
DII	12,63,34,616	12.55 %	-0.38
MF	6,75,54,708	6.71 %	-0.28
Others	6,78,25,062	6.75 %	-0.34

MF Ownership

Kotak Flexicap Direct-G
Equity: Flexi Cap
3
- 1,039.37
  Amount Invested (in Cr.)
- 2.19%
  % of AUえーゆーM
- -2.24
  % Change (MoM basis)
Parag Parikh Flexi Cap Direct-G
Equity: Flexi Cap
5
- 732.22
  Amount Invested (in Cr.)
- 1.15%
  % of AUえーゆーM
- 0.00
  % Change (MoM basis)
Kotak Emerging Equity Direct-G
Equity: Mid Cap
4
- 405.09
  Amount Invested (in Cr.)
- 0.95%
  % of AUえーゆーM
- 0.00
  % Change (MoM basis)

MF Ownership as on 30 April 2024

View all Mutual Fund Schemes

Cadila Healthcare F&O Quote

Futures
Options

- Expiry
Price
1,054.25-6.95 (-0.65%)
Open Interest
82,64,70021,19,500 (25.65%)
Open High Low Prev Close Contracts Traded Turnover (₹ Lakhs)
1,064.20 1,070.70 1,041.15 1,061.20 6,199 58,880.17
Open Interest as of 24 Apr 2024

Open	High	Low	Prev Close	Contracts Traded	Turnover (₹ Lakhs)
1,064.20	1,070.70	1,041.15	1,061.20	6,199	58,880.17

Corporate Actions

Cadila Healthcare Board Meeting/AGM
Cadila Healthcare Dividends
Others

Meeting Date	Announced on	Purpose	Details
May 17, 2024	May 09, 2024	Board Meeting	Audited Results & Final Dividend
Feb 09, 2024	Feb 05, 2024	Board Meeting	Quarterly Results & Buy Back of shares
Nov 07, 2023	Oct 30, 2023	Board Meeting	Quarterly Results
Aug 11, 2023	Jul 31, 2023	Board Meeting	Quarterly Results
Aug 11, 2023	May 18, 2023	AGM	-

Type	Dividend	Dividend per Share	Ex-Dividend Date	Announced on
Final	600%	6.0	Jul 28, 2023	May 18, 2023
Final	250%	2.5	Jul 28, 2022	May 20, 2022
Final	350%	3.5	Jul 28, 2021	May 27, 2021
Interim	350%	3.5	Mar 23, 2020	Mar 11, 2020
Final	300%	3.0	-	May 17, 2024

All Types	Ex-Date	Record Date	Announced on	Details
Splits	Oct 06, 2015	Oct 07, 2015	Aug 12, 2015	Split: Old FV5.0\| New FV:1.0
Bonus	Apr 05, 2010	Apr 06, 2010	Feb 25, 2010	Bonus Ratio: 1 share(s) for every 2 shares held
Bonus	Aug 30, 2006	Aug 31, 2006	Apr 28, 2006	Bonus Ratio: 1 share(s) for every 1 shares held

About Cadila Healthcare

Zydus Lifesciences Ltd., incorporated in the year 1995, is a Large Cap company (having a market cap of Rs 106,509.87 Crore) operating in Pharmaceuticals sector. Zydus Lifesciences Ltd. key Products/Revenue Segments include Pharmaceutical Products, Other Operating Revenue and Export Incentives for the year ending 31-Mar-2023. Show More

Executives
Auditors

PR
Pankaj R Patel
Chairman
SP
Sharvil P Patel
Managing Director
GN
Ganesh N Nayak
Executive Director
MM
Mukesh M Patel
Non Executive Director
AS
Apurva S Diwanji
Independent Director
BK
Bhadresh K Shah
Independent Director
DN
Dharmishtaben N Raval
Independent Woman Director
MA
Monappa Arun Akhil
Independent Director
NR
Nitin R Desai
Independent Director
UK
Upasana Konidela
Independent Woman Director
ND
Nitin D Parekh
Chief Financial Officer
DN
Dhaval N Soni
Co. Secretary & Compl. Officer
Show More
Deloitte Haskins & Sells LLP

Industry

Pharma - Indian

Key Indices Listed on

Nifty Next 50, Nifty 100, Nifty 200, + 26 more

Address

Zydus Corporate Park, Scheme No.63,Survey No. 536, Khoraj (Gandhinagar),Nr. Vaishnodevi Circle,Ahmedabad, Gujarat - 382481

Contact

investor.grievance@zyduscadila.com

http://www.zyduslife.com

More Details

FAQs about Cadila Healthcare share

1. What is Cadila Healthcare share price and what are the returns for Cadila Healthcare share?
Cadila Healthcare share price was Rs 1,046.65 as on 29 May, 2024, 02:34 PM IST. Cadila Healthcare share price was down by 0.60% based on previous share price of Rs. 1058.5. In last 1 Month, Cadila Healthcare share price moved up by 8.68%.
2. What is 52 week high/low of Cadila Healthcare share price?
In last 52 weeks Cadila Healthcare share had a high price of Rs 1,172.50 and low price of Rs 498.85
3. What is the market cap of Cadila Healthcare?
Cadila Healthcare share has a market capitalization of Rs 1,05,951 Cr. Within Pharmaceuticals sector, it's market cap rank is 4.
4. Who owns Cadila Healthcare?
Following are the key changes to Cadila Healthcare shareholding:
- Promoter holding has not changed in last 9 months and holds 74.98 stake as on 31 Mar 2024
- Domestic Institutional Investors holding have gone down from 13.44 (30 Jun 2023) to 12.55 (31 Mar 2024)
- Foreign Institutional Investors holding has gone up from 4.04 (30 Jun 2023) to 5.72 (31 Mar 2024)
- Other investor holding have gone down from 7.53 (30 Jun 2023) to 6.75 (31 Mar 2024)
5. Which are the key peers to Cadila Healthcare?
Top 10 Peers for Cadila Healthcare are Divi's Laboratories Ltd., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Torrent Pharmaceuticals Ltd., Mankind Pharma Ltd., Lupin Ltd., Aurobindo Pharma Ltd., Alkem Laboratories Ltd., Biocon Ltd. and Ipca Laboratories Ltd.
6. How can I quickly analyze Cadila Healthcare stock?
Cadila Healthcare share can be quickly analyzed on following metrics:
- Stock's PE is 27.01
- Price to Book Ratio of 4.79

Trending in Markets

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.

1 Day	-0.42%
1 Week	-2.84%
1 Month	8.55%
3 Months	10.96%
1 Year	104.25%
3 Years	68.35%
5 Years	296.68%

Zydus Lifesciences Share Price